The World Health Organization (WHO) has validated Algeria as having eliminated trachoma as a public health problem, making it the 10th country in WHO’s African Region and the 29th globally to reach this milestone.
Trachoma, the leading infectious cause of blindness worldwide, remains endemic in 30 countries and causes blindness or visual impairment in about 1.9 million people.
“Algeria’s elimination of trachoma is a historic triumph rooted in a century-long commitment,” said WHO Director-General Dr. Tedros Ghebreyesus. “This milestone proves that with sustained political will and dedicated health professionals, neglected tropical diseases can be eliminated, building a healthier, more resilient future for all.”
About 97 million people still live in trachoma-endemic areas at risk of blindness. The disease, caused by Chlamydia trachomatis, spreads through contact with infected eye discharge via hands, clothing, or flies. Repeated infections can lead to trachomatous trichiasis, a painful condition that may cause blindness.
Algeria’s fight against trachoma began in the early 20th century with the Pasteur Institute of Algeria. Post-independence, Algerian physicians led efforts strengthened by a national public healthcare system that provided free services from 1974.
For decades, Algeria implemented WHO’s SAFE Strategy: surgery for advanced cases, mass antibiotic treatment, hygiene campaigns, and improved water and sanitation access.
Between 2013–2015, a focused strategy targeted 12 southern wilayas where trachoma persisted. Surveys in 2022 confirmed the elimination threshold was achieved in all areas, with remaining TT cases fully addressed through door-to-door management.
In December 2025, Algeria submitted evidence to WHO demonstrating that the country met criteria for trachoma elimination, supported by a well-functioning school health system, extensive eye care coverage, and broad access to water and sanitation.
“Trachoma devastates communities, causing painful economic and livelihood losses. Algeria’s milestone transforms the health and well-being of children, women, and families, showing that eliminating neglected tropical diseases is possible,” said Dr. Mohamed Janabi, WHO Regional Director for Africa.
WHO recommends continued surveillance post-validation to ensure no resurgence. The organization is supporting Algeria’s health authorities in this effort.
“WHO’s validation reflects decades of sustained effort, multisectoral coordination, and national commitment,” said Prof. Mohamed Seddik Ait Messaoudene, Algerian Minister of Health. “This achievement is the result of nearly 50 years of mobilization, stakeholder collaboration, and dedicated health professionals.”
